文献速递血栓与止血

纤维蛋白原基因型及其对静脉血栓栓塞复发和家族史的影响:一项前瞻性人群研究

Fibrinogen genotypes and their impact on recurrence of venous thromboembolism and family history: A prospective population-based study.
PubMed 文献 · Br J Haematol · 2025-01-19

在马尔默血栓形成倾向研究中,对1465例静脉血栓栓塞(VTE)患者随访约10年及429名健康供者进行纤维蛋白原基因常见错义变异分型。调整年龄和性别后,FGG(rs6063)与原发性VTE风险升高相关(OR=8.2;95%CI=1.05-63.6);FGA(rs6050)与复发性VTE风险升高相关(HR=1.8;95%CI=1.1-2.8),无诱因复发风险更高(HR=2.3;95%CI=1.3-4.2)。

要点

  • FGG(rs6063)与原发性VTE风险升高相关(OR=8.2;95%CI=1.05-63.6)。
  • FGA(rs6050)与复发性VTE风险升高相关(HR=1.8;95%CI=1.1-2.8),无诱因复发风险更高(HR=2.3;95%CI=1.3-4.2)。
  • 联合FVL与FGA(rs6050)风险等位基因可显著增加无诱因复发VTE风险。

核心结论

  • 作者提出FGA(rs6050)可作为无诱因复发性VTE的新预测因子,并可能促进VTE的家族性发生。

研究设计与样本

  • 前瞻性人群研究,纳入马尔默血栓形成倾向研究的1465例VTE患者(随访约10年)和429名健康供者,对纤维蛋白原基因常见错义变异进行基因分型。

主要发现

  • 调整年龄和性别后,FGG(rs6063)与原发性VTE风险升高相关(OR=8.2;95%CI=1.05-63.6)。
  • Cox回归分析显示,FGA(rs6050)与复发性VTE风险升高相关(HR=1.8;95%CI=1.1-2.8),无诱因复发性VTE风险更高(HR=2.3;95%CI=1.3-4.2),超过已知的因子V Leiden(FVL)(HR=1.9;95%CI=1.2-3.0)。
  • 联合FVL与FGA(rs6050)风险等位基因显著增加无诱因复发性VTE风险:≥3个风险等位基因(HR=4.6;95%CI=1.9-11.3)、2个风险等位基因(HR=2.6;95%CI=1.4-4.8)、1个风险等位基因(HR=1.5;95%CI=0.8-2.7),均与0个风险等位基因相比。
  • 有VTE家族史的患者中FGA(rs6050)风险等位基因的患病率显著更高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Venous thromboembolism (VTE) involves blood clot formation in veins, resulting in serious health issues. Fibrinogen, a crucial clotting protein, consists of three polypeptides encoded by the fibrinogen genes: alpha (FGA), beta (FGB) and gamma (FGG). We genotyped most common missense variants in the fibrinogen genes in relation to VTE, recurrence and family history in Malmö Thrombophilia Study, including 1465 VTE patients followed for ~10 years and 429 healthy donors. FGG (rs6063) was significantly associated with increased odds of primary VTE (odds ratio [OR] = 8.2; 95% confidence interval [CI] = 1.05-63.6) after adjusting for age and sex. For recurrent VTE, Cox-regression analysis indicated a higher risk associated with FGA (rs6050) (hazard ratio [HR] = 1.8; 95% CI = 1.1-2.8), with even greater risk for unprovoked recurrent VTE (HR = 2.3; 95% CI = 1.3-4.2), surpassing the well-known factor V Leiden (FVL) (HR = 1.9; 95% CI = 1.2-3.0). Combining risk alleles from FVL and FGA (rs6050) significantly raised the risk for unprovoked recurrent VTE: ≥3 risk alleles (HR = 4.6; 95% CI = 1.9-11.3), two risk alleles (HR = 2.6; 95% CI = 1.4-4.8) and one risk allele (HR = 1.5; 95% CI = 0.8-2.7) compared to 0 risk allele. Prevalence of FGA (rs6050) risk allele was significantly higher in cases with a family history of VTE. We propose FGA (rs6050) as a novel predictor for unprovoked recurrent VTE and it may contribute to the familial occurrence of VTE.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Memon AA, Zöller B, Svensson PJ, et al. Fibrinogen genotypes and their impact on recurrence of venous thromboembolism and family history: A prospective population-based study. Br J Haematol. 2025. PMID: 39828282. doi:10.1111/bjh.19999

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。